Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Martin

Showing results (161-170 of 216) with videos related to

Pageof 22
Sort By:
Journal of Clinical Medicine|August 28, 2025
Intrathecal Anti-<i>Akkermansia muciniphila</i> IgG Responses in Multiple Sclerosis Patients Linked to CSF Immune Cells and Disease ActivityCarolina Cruciani, Camille Mathé, Marco Puthenparampil, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2004
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon betaBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and peripheryKazuyuki Kawamura, Karen Yao, Jacqueline A Shukaliak-Quandt, et al.
Journal of Virology|January 11, 2013
T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsIlijas Jelcic, Lilian Aly, Thomas M C Binder, et al.
Multiple Sclerosis International|August 14, 2012
Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomographyTimm Oberwahrenbrock, Sven Schippling, Marius Ringelstein, et al.
Acta Neuropathologica|June 25, 2017
Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathologyBenjamin V Ineichen, Sandra Kapitza, Christiane Bleul, et al.
Human Molecular Genetics|August 14, 2003
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseRoberto Bomprezzi, Markus Ringnér, Seungchan Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26Vera Preller, Annegret Gerber, Sabine Wrenger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2021
T-Cell Specificity Influences Disease Heterogeneity in Multiple SclerosisCarolina Cruciani, Marco Puthenparampil, Paula Tomas-Ojer, et al.
Brain : a Journal of Neurology|March 19, 2010
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosisManuel Comabella, Marta Fernández, Roland Martin, et al.
Pageof 22

Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Journal of Clinical Medicine|August 28, 2025
Intrathecal Anti-<i>Akkermansia muciniphila</i> IgG Responses in Multiple Sclerosis Patients Linked to CSF Immune Cells and Disease ActivityCarolina Cruciani, Camille Mathé, Marco Puthenparampil, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2004
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon betaBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and peripheryKazuyuki Kawamura, Karen Yao, Jacqueline A Shukaliak-Quandt, et al.
Journal of Virology|January 11, 2013
T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsIlijas Jelcic, Lilian Aly, Thomas M C Binder, et al.
Multiple Sclerosis International|August 14, 2012
Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomographyTimm Oberwahrenbrock, Sven Schippling, Marius Ringelstein, et al.
Acta Neuropathologica|June 25, 2017
Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathologyBenjamin V Ineichen, Sandra Kapitza, Christiane Bleul, et al.
Human Molecular Genetics|August 14, 2003
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseRoberto Bomprezzi, Markus Ringnér, Seungchan Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26Vera Preller, Annegret Gerber, Sabine Wrenger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2021
T-Cell Specificity Influences Disease Heterogeneity in Multiple SclerosisCarolina Cruciani, Marco Puthenparampil, Paula Tomas-Ojer, et al.
Brain : a Journal of Neurology|March 19, 2010
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosisManuel Comabella, Marta Fernández, Roland Martin, et al.
Pageof 22